Johnson & Johnson will buy Micrus Endovascular Corp. for about $480 million to expand its portfolio of medical devices that treat stroke, the companies said on Monday.
*For more on this story, read the full Reuters article.
Johnson & Johnson will buy Micrus Endovascular Corp. for about $480 million to expand its portfolio of medical devices that treat stroke, the companies said on Monday.
*For more on this story, read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99